Amica Insurance: Back To Zero
Recent ad shows what it takes to make a comeback.
Similasan Eye Relief
Case Name (Date)
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Product/Service
Similasan Eye Relief products
Allegations
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Status
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
The Latest
Will the MLM Industry Fix Its Earnings Claims Problem?
New research points to “no.”
TINA.org Supports Citizen Petition Calling for AI Pricing Transparency
Why disclosures are key to protecting informed consumer choice and competition.
James ‘Jay’ Noland’s Latest Ventures Raise Familiar Concerns
Permanently banned from MLM, Noland has found other ways to exploit consumers.
Broadway.com
Pulling back the curtain on this official-sounding website.